Market Overview:
The global inhaled corticosteroid market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing prevalence of respiratory diseases, rising awareness about asthma and other respiratory disorders, and the growing demand for technologically advanced inhalers. Based on type, the global inhaled corticosteroid market is segmented into beclomethasone dipropionate, budesonide, fluticasone inhaler powder, mometasone furoate monohydrate (MF), and others. The beclomethasone dipropionate segment is expected to account for the largest share of the global market in 2018. This segment is also projected to grow at a CAGR of 5.7% during the forecast period from 2018 to 2030. This growth can be attributed to its high efficacy in treating asthma and other respiratory disorders and its wide availability across regions worldwide. Based on application, hospitals are estimated to account for the largest share ofthe global inhaled corticosteroid market in 2018 followed by clinicsand respiratory care centers respectively . However , clinics are projectedto witness higher growth rates than hospitals duringthe forecast period from2018-2030 owing tobetter patient accessibilityand affordabilityin this sector .
Product Definition:
Inhaled corticosteroids are a class of medications that are used to prevent and treat asthma attacks. They work by decreasing inflammation in the airways, which helps to open them up and make breathing easier. Inhaled corticosteroids are very important for people with asthma, as they can help reduce the number of attacks and improve lung function.
Beclomethasone Dipropionate:
Beclomethasone dipropionate, sold under the brand nameBeconase among others is a medication used to treat asthma and other respiratory disorders. It works by reducing inflammation of the lungs. The drug was first approved in the U.S in 1970 and globally in 1980.
Budesonide:
Budesonide is a type of bronchodilator which works by relaxing the smooth muscles in the airways, allowing them to dilate and widen. It is used as an anti-inflammatory drug for treating asthma and other breathing disorders. The medicine comes in both branded (Nasacort) and generic forms.
Application Insights:
The others segment held the largest share of over 70.0% in 2017. The application includes asthma treatment and other respiratory disorders, such as bronchospasm, laryngitis, and allergic rhinitis among others. In addition to this, the segment also comprises of various chronic diseases that require long-term inhalation therapy including diabetes mellitus type II and rheumatoid arthritis among others. These factors are anticipated to increase product demand in the coming years.
Based on usage patterns for asthma treatment or not; these products can be used alone or along with other medications for treating asthma effectively; they can also be used as a substitute medication when other medicines fail to work properly; these factors are expected to drive their demand from clinics & hospitals at a lucrative rate during the forecast period especially across North America.
Regional Analysis:
North America dominated the global inhaled corticosteroid market in 2016 with a revenue share of over 40.0%. The growth is majorly attributed to increasing prevalence of COPD and rising healthcare expenditure in the region. According to Global Initiative for Asthma (GINA), around 6 million people suffer from asthma in U.S., which is expected to increase due to exposure to triggers such as pollution, dust, and allergens among others which results into development of COPD. In addition, presence of key players such as GlaxoSmithKline plc.; Pfizer Inc.; Merck & Co., Inc.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing high demand for generic drugs coupled with growing population suffering from respiratory disorders such as asthma.
Growth Factors:
- Increasing prevalence of respiratory diseases: The global Inhaled Corticosteroid market is expected to grow at a CAGR of 5.5% during the forecast period, owing to the increasing prevalence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD).
- Growing awareness about the benefits of Inhaled Corticosteroids: There is a growing awareness among patients about the benefits of using Inhaled Corticosteroids for treating respiratory diseases. This is likely to boost demand for these drugs in the coming years.
- Technological advancements in inhalers: The development of novel inhalers that deliver drugs directly to the lungs is expected to drive growth in the Inhaled Corticosteroid market during the forecast period. These inhalers are easier and more comfortable to use, which is likely to increase their adoption among patients worldwide.
- Rising geriatric population: The global geriatric population is growing at a rapid pace, which is leading to an increase in cases of respiratory diseases such as asthma and COPD. This will create significant opportunities for players operating in the Inhaled Corticosteroid market overthe next few years .
Scope Of The Report
Report Attributes
Report Details
Report Title
Inhaled Corticosteroid Market Research Report
By Type
Beclomethasone Dipropionate, Budesonide, Fluticasone Inhaler Powder, Mometasone, Others
By Application
Hospitals, Clinics, Respiratory Care Centers, Others
By Companies
Sumitomo, Pfizer, Novartis, Merck, Sanofi, Johnson and Johnson, GSK, AstraZeneca, Teijin, Glaxo's Advair, Amgen, Kos Pharmaceutical, Teva Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Inhaled Corticosteroid Market Report Segments:
The global Inhaled Corticosteroid market is segmented on the basis of:
Types
Beclomethasone Dipropionate, Budesonide, Fluticasone Inhaler Powder, Mometasone, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Respiratory Care Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sumitomo
- Pfizer
- Novartis
- Merck
- Sanofi
- Johnson and Johnson
- GSK
- AstraZeneca
- Teijin
- Glaxo's Advair
- Amgen
- Kos Pharmaceutical
- Teva Pharmaceutical
Highlights of The Inhaled Corticosteroid Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Beclomethasone Dipropionate
- Budesonide
- Fluticasone Inhaler Powder
- Mometasone
- Others
- By Application:
- Hospitals
- Clinics
- Respiratory Care Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Inhaled Corticosteroid Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Inhaled corticosteroids are medications that are inhaled into the lungs to treat a variety of conditions. These medications work by reducing inflammation and swelling in the airways.
Some of the key players operating in the inhaled corticosteroid market are Sumitomo, Pfizer, Novartis, Merck, Sanofi, Johnson and Johnson, GSK, AstraZeneca, Teijin, Glaxo's Advair, Amgen, Kos Pharmaceutical, Teva Pharmaceutical.
The inhaled corticosteroid market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Inhaled Corticosteroid Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Inhaled Corticosteroid Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Inhaled Corticosteroid Market - Supply Chain
4.5. Global Inhaled Corticosteroid Market Forecast
4.5.1. Inhaled Corticosteroid Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Inhaled Corticosteroid Market Size (000 Units) and Y-o-Y Growth
4.5.3. Inhaled Corticosteroid Market Absolute $ Opportunity
5. Global Inhaled Corticosteroid Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Inhaled Corticosteroid Market Size and Volume Forecast by Type
5.3.1. Beclomethasone Dipropionate
5.3.2. Budesonide
5.3.3. Fluticasone Inhaler Powder
5.3.4. Mometasone
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Inhaled Corticosteroid Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Inhaled Corticosteroid Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Respiratory Care Centers
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Inhaled Corticosteroid Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Inhaled Corticosteroid Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Inhaled Corticosteroid Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Inhaled Corticosteroid Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Inhaled Corticosteroid Demand Share Forecast, 2019-2026
9. North America Inhaled Corticosteroid Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Inhaled Corticosteroid Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Inhaled Corticosteroid Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Respiratory Care Centers
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Inhaled Corticosteroid Market Size and Volume Forecast by Type
9.7.1. Beclomethasone Dipropionate
9.7.2. Budesonide
9.7.3. Fluticasone Inhaler Powder
9.7.4. Mometasone
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Inhaled Corticosteroid Demand Share Forecast, 2019-2026
10. Latin America Inhaled Corticosteroid Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Inhaled Corticosteroid Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Inhaled Corticosteroid Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Respiratory Care Centers
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Inhaled Corticosteroid Market Size and Volume Forecast by Type
10.7.1. Beclomethasone Dipropionate
10.7.2. Budesonide
10.7.3. Fluticasone Inhaler Powder
10.7.4. Mometasone
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Inhaled Corticosteroid Demand Share Forecast, 2019-2026
11. Europe Inhaled Corticosteroid Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Inhaled Corticosteroid Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Inhaled Corticosteroid Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Respiratory Care Centers
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Inhaled Corticosteroid Market Size and Volume Forecast by Type
11.7.1. Beclomethasone Dipropionate
11.7.2. Budesonide
11.7.3. Fluticasone Inhaler Powder
11.7.4. Mometasone
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Inhaled Corticosteroid Demand Share, 2019-2026
12. Asia Pacific Inhaled Corticosteroid Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Inhaled Corticosteroid Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Inhaled Corticosteroid Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Respiratory Care Centers
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Inhaled Corticosteroid Market Size and Volume Forecast by Type
12.7.1. Beclomethasone Dipropionate
12.7.2. Budesonide
12.7.3. Fluticasone Inhaler Powder
12.7.4. Mometasone
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Inhaled Corticosteroid Demand Share, 2019-2026
13. Middle East & Africa Inhaled Corticosteroid Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Inhaled Corticosteroid Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Inhaled Corticosteroid Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Respiratory Care Centers
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Inhaled Corticosteroid Market Size and Volume Forecast by Type
13.7.1. Beclomethasone Dipropionate
13.7.2. Budesonide
13.7.3. Fluticasone Inhaler Powder
13.7.4. Mometasone
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Inhaled Corticosteroid Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Inhaled Corticosteroid Market: Market Share Analysis
14.2. Inhaled Corticosteroid Distributors and Customers
14.3. Inhaled Corticosteroid Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sumitomo
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Pfizer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Novartis
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Merck
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Sanofi
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Johnson and Johnson
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. GSK
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. AstraZeneca
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Teijin
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Glaxo's Advair
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Amgen
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Kos Pharmaceutical
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Teva Pharmaceutical
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
